SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-10-013737
Filing Date
2010-03-11
Accepted
2010-03-11 16:15:34
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a10-1895_110k.htm 10-K 1902266
2 EX-10.30 a10-1895_1ex10d30.htm EX-10.30 17079
3 EX-21.1 a10-1895_1ex21d1.htm EX-21.1 3146
4 EX-23.1 a10-1895_1ex23d1.htm EX-23.1 4888
5 EX-31.1 a10-1895_1ex31d1.htm EX-31.1 10159
6 EX-31.2 a10-1895_1ex31d2.htm EX-31.2 10763
7 EX-32 a10-1895_1ex32.htm EX-32 9158
8 GRAPHIC g18951bii001.gif GRAPHIC 9022
  Complete submission text file 0001104659-10-013737.txt   1971451
Mailing Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121
Business Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 8589090736
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33291 | Film No.: 10674240
SIC: 2834 Pharmaceutical Preparations